Skip to main content
. 2022 Aug 3;9:962566. doi: 10.3389/fnut.2022.962566

TABLE 1.

Baseline characteristics of the subjects participating in the study.

Total (N = 255) Control group (N = 128) Probiotic group (N = 127) P between groups
Age (years) 41.33 ± 11.35 41.34 ± 11.57 41.32 ± 11.18 0.993
Sex 0.325
Men 42 (16.5%) 24 (18.7%) 18 (14.2%)
Women 213 (83.5%) 104 (81.3%) 109 (85.8%)
BMI 24.69 ± 4.47 25.03 ± 4.99 24.35 ± 3.87 0.225
BMI classification 0.186
Normal weight 145 (56.9%) 74 (57.8%) 71 (55.9%)
Overweight 74 (29.0%) 31 (24.2%) 43 (33.9%)
Obese 31 (12.2%) 20 (15.6%) 11 (8.7%)
Low weight 5 (2.0%) 3 (2.3%) 2 (1.6%)
Smokers 61 (23.9%) 36 (28.1%) 25 (19.7%) 0.114
Dyslipidaemia 8 (3.1%) 4 (3.1%) 4 (3.1%) 0.991
Hypertension 16 (6.3%) 8 (6.3%) 8 (6.3%) 0.987
Diabetes 9 (3.5%) 3 (2.3%) 6 (4.7%) 0.303
Cardiovascular disease 5 (3.1%) 1 (0.8%) 4 (3.1%) 0.173
Chronic lung disease 5 (3.1%) 4 (3.1%) 1 (0.8%) 0.178
Past cancer disease 4 (1.6%) 2 (1.6%) 2 (1.6%) 0.994
Disease index 1 0.27 ± 0.61 0.29 ± 0.59 0.25 ± 0.62 0.558
Risk Factors score 2 0.51 ± 0.77 0.58 ± 0.80 0.45 ± 0.74 0.182

Values are mean ± SD for continuous variables and n (%) for categorical variables. P indicates differences between the control group and the probiotic group. 1Disease Index included the sum of HTA, T2DM, CVD, Lung diseases, oncology disease in the past and dyslipidemia. 2Risk factors score included disease index + smokers.